Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

January 8, 2021

CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562

International Journal of Laboratory Hematology
Juan LiJingchun Jin
January 8, 2021
Open Access

Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview

Frontiers in Oncology
Alessandro BarbatoAlessandra Romano
January 13, 2021

Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Genes, Chromosomes & Cancer
Christina Orsmark-PietrasVladimir Lj Lazarevic
January 13, 2021

Expression of CD304/neuropilin-1 in adult b-cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment

International Journal of Laboratory Hematology
Gaurav ChatterjeePrashant R Tembhare
January 7, 2021
Open Access

Dual Kinase Targeting in Leukemia

Luca MologniAlfonso Zambon
January 15, 2021

Treatment Outcomes of Intracranial Myeloid Sarcomas: A Meta-Analysis

World Neurosurgery
Dennis LeeKiarash Shahlaie
January 20, 2021

Novel developments in chronic myeloid leukaemia

Current Opinion in Hematology
Patrick Harrington, Hugues de Lavallade
January 10, 2021
Case Report
Open Access

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation

International Journal of Molecular Sciences
Valentina GiudiceGiovanni Martinelli
January 9, 2021
Open Access

Sustained dasatinib treatment prevents early fibrotic changes following ocular trauma

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Shunichiro UedaShigeo Tamiya
January 20, 2021

Cells with Higher Cortical Membrane Tension Are More Sensitive to Lysis by Biosurfactant Di-rhamnolipids

ACS Biomaterials Science & Engineering
Chong ShenQin Meng
January 14, 2021
Open Access

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

World Journal of Clinical Oncology
Ruth StuckeyMaría Teresa Gómez-Casares

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is rare lymphoproliferative disorder unicentric (localized) or multicentric (systemic). Discover the latest research here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2021 Meta ULC. All rights reserved